Article Per Year (5 Year)
p-Index From 2021 - 2026
0
P-Index
This Author published in this journals
All Journal Cermin Dunia Kedokteran
Jafar, Yohanes
Unknown Affiliation
Health Professions Medicine & Pharmacology Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Tatalaksana Multiple Sclerosis Jafar, Yohanes
Cermin Dunia Kedokteran Vol 44, No 3 (2017): Infeksi
Publisher : PT. Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (171.422 KB) | DOI: 10.55175/cdk.v44i3.830

Abstract

Multiple sclerosis adalah suatu kelainan autoimun, yaitu sistem kekebalan tubuh sendiri menyerang sistem saraf pusat. Gejalanya sangat beragam, seperti penurunan penglihatan pada salah satu mata, penglihatan ganda, kelainan sensorik, dan gangguan keseimbangan. Prevalensi global kelainan ini sangat beragam; di Indonesia, termasuk jarang. MRI dapat membantu menegakkan diagnosis. Belakangan ini banyak obat-obat golongan DMAMS (disease-modifying agents for MS) yang ditujukan untuk mengurangi progresivitas dan relaps penyakit ini. Pemilihan obat DMAMS sebaiknya juga memperhatikan efek samping obat dan kenyamanan pasien.Multiple Sclerosis is an autoimmune disorder that the body's own immune system attacks the central nervous system. The symptoms of these disorders are very diverse, such as loss of vision in one eye, double vision, sensory abnormalities, and balance disorders. Globally, the prevalence of this disorder varies between regions, it is considered rare in Indonesia. MRI can help diagnose this disorder. Drugs from DMAMS (disease-modifying agents for MS) group are intended to reduce progression and relapse. DMAMS drug selection should also consider potential side effects and patient comfort.
Co-Authors